HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy. - Nozawa K; Sawaki M; Uemura Y; Tsuneizumi M; Takano T; Gondo N; Hara F; Harao M; Toyama T; Taira N; Vivancos A; Perou CM; et al. (Nature communications, 2025)